Compounds > ha 1004
Page last updated: 2024-10-28

ha 1004 and Acute Myelogenous Leukemia

ha 1004 has been researched along with Acute Myelogenous Leukemia in 2 studies

N-(2-guanidinoethyl)-5-isoquinolinesulfonamide: structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martell, RE1
Simpson, RU1
Hsu, T1
Nishikawa, M1
Uemura, Y1
Hidaka, H1
Shirakawa, S1

Other Studies

2 other studies available for ha 1004 and Acute Myelogenous Leukemia

ArticleYear
Effects of protein kinase inhibitors 1(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7) and N-[2-guanidinoethyl]-5-isoquinolinesulfonamide hydrochloride (HA1004) on calcitriol-induced differentiation of HL-60 cells.
    Biochemical pharmacology, 1988, Feb-15, Volume: 37, Issue:4

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Calcitriol; Cell Differentiation; Cell Survival; DNA,

1988
1-(5-Isoquinolinesulfonyl)-2-methylpiperazine(H-7), a potent inhibitor of protein kinases, inhibits the differentiation of HL-60 cells induced by phorbol diester.
    Life sciences, 1986, Sep-22, Volume: 39, Issue:12

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Cell Differentiation; Cell Division; Cell Line; Depre

1986